What You Should Know:
- Imagene AI, an emerging leader in the field of AI-based precision medicine for cancer, today announced it raised $21.5 million, comprising $3M in seed funding led by Blumberg Capital and an $18.5M Series A round led by renowned technology-driven cancer medicine investors Larry Ellison, Dr. David Agus, and AI imaging space pioneer Eyal Gura.
- The use of AI-based molecular testing in cancer diagnostics is revolutionizing patient care by offering a new level of
Read More
Cancer Diagnostics
Black Female Co-founders CancerIQ Raises $14M to Improve Cancer Early Detection and Prevention
What You Should Know:
- CancerIQ, a Chicago-based platform powering early cancer detection and prevention across broad patient populations, announced today it closed a $14M Series B financing round.
- The Series B round was co-led by Merck Global Health Innovation Fund (Merck GHI) and Amgen Ventures with participation from McKesson Ventures, OSF Ventures (the investment arm of OSF HealthCare, a current CancerIQ customer), and HealthX Ventures.
Inequality in
Read More
Notable Labs Launches by Acquiring Rights to Volasertib – Will Use Data, AI to Fast-Track Cancer Treatment
What You Should Know:
- Coming out of stealth, Notable Labs, a pioneer and developer of predictive precision medicines, is acquiring worldwide development and commercial rights to volasertib, a PLK-1 inhibitor in acute myeloid leukemia (AML) from Oncoheroes.
- Notable will leverage its high-fidelity Predictive Precision Medicines Platform to identify and select volasertib-responsive patients prior to their treatment and fast-track volasertib’s clinical development
Read More
Corindus Vascular Robotics CEO Departure, UPMC Enterprises’ New President, Nordic Consulting’s New CIO, Other Health IT Hires
Mark Toland, CEO of Corindus Vascular Robotics (acquired by Siemens for $1.1B last year), has announced his departure and will be joining BioStar Capital, a health-tech venture capital group focused on cardiovascular and orthopedic medical devices. As a partner and entrepreneur in residence, Mark will help to identify and develop innovative companies leveraging AI, deep learning, robotics, and other transformative technologies that address a wide range of unmet needs. The BioStar team has
Read More
UK Cancer Diagnostics Startup Biofidelity Raises $12M
What You Should Know:
- UK-based Biofidelity raises $12 million in Series A funding to accelerate the launch of disruptive cancer diagnostic technology.
- The funding will be used to bring technology to market,
enabling a dramatic simplification of precision genetic testing to ensure many
more cancer patients receive optimal diagnosis and therapy.
Biofidelity Ltd, a Cambridge,
UK-based cancer diagnostics company, today announced it has raised $12 million
in Series A funding led by
Read More
Top 60 Health IT/Digital Health Mergers & Acquisitions in 2019
- From Google's acquisition of Fitbit to Philips acquisition of Carestream Health's health IT business, here is a look at some of the biggest health IT/digital health mergers & acquisitions in 2019 by each quarter.
Q1 M&A Activity
Johnson & Johnson Acquires Auris Health for $3.4B to Expand Digital Surgery Portfolio
Johnson & Johnson acquiresAuris Health, a developer of robotic technologies for $3.4 billion in cash. Auris Health is a privately-held developer of
Read More
Philips, Paige Partner to Deliver Clinical Grade AI Apps to Pathology Laboratories
- Philips and Paige form a strategic partnership to deliver AI-based cancer assessment tools are poised to help pathologists improve speed and accuracy of cancer diagnostics, ultimately leading to better patient care. - Philips IntelliSite Pathology Solution in combination with Paige Prostate aims to provide an intuitive digital & computational pathology workflow experience. Philips plans to offer the CE-marked Paige Prostate to European pathology labs in 2020.Philips today announced a
Read More
IBM Watson Health Unveils Imaging AI Marketplace of FDA-Cleared Solutions
- IBM Watson Health unveils two new products at RNSA 2019, Clinical Review 3.0 and The Imaging AI Marketplace. - Clinical Review 3.0, a tool recently launched in the UK that analyzes medical imaging studies and their associated reports to identify potentially missed findings, facilitating higher quality and more comprehensive care for the patient.- The Imaging AI Marketplace is a single-source solution designed to help simplify the complex process of locating, purchasing, deploying and managing
Read More
Pittsburgh Health Data Alliance, Amazon Partner on Machine Learning Research Sponsorship
Pittsburgh Health Data Alliance (PHDA) announced today that it is working closely with Amazon Web Services (AWS), an Amazon.com company, through a machine learning research sponsorship, to advance innovation in areas such as cancer diagnostics, precision medicine, voice-enabled technologies and medical imaging.Leveraging Machine Learning to Power Medical ResearchA unique consortium formed four years ago by UPMC, the University of Pittsburgh and Carnegie Mellon University (CMU), the PHDA uses
Read More
Adventist Integrates CancerIQ Platform with Cerner EHR Systemwide to Get AHEAD of Cancer
Adventist Health is getting AHEAD of hereditary cancer (which tends to be earlier onset, more aggressive, and accounts for 10 percent of all new diagnoses). The Adventist Health Early All-Around Detection – or AHEAD Program – at Adventist Health is a population hereditary cancer risk assessment initiative.To ensure patients in both urban and rural settings have access to the preventive services needed to reduce risk, Adventist Health is partnering with CancerIQ to identify candidates for genetic
Read More
